Skip to content
Bamboo Works
Search
Sign in / Register
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • Huazhu
    • Pop Mart
    • Tuya
    • Yalla
    • Yum China
  • Expert Corner
  • Premium Content
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • 简中
  • 繁中
  • Eng
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • Huazhu
    • Pop Mart
    • Tuya
    • Yalla
    • Yum China
  • Expert Corner
  • Premium Content
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

AIM Vaccine

AIM Vaccine Shrinks Its IPO But Gives Chairman a Mega Paycheck

China’s second-largest maker of non-Covid vaccines has finally crossed the IPO finish line and will list its shares next Thursday Key Takeaways: AIM Vaccine is finally landing on the Hong…
September 30, 2022

AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt

Vaccine maker’s previous IPO bids on Shenzhen’s ChiNext board and in Hong Kong failed, but it is soldiering ahead with a new attempt in Hong Kong Key takeaways: Vaccine maker AIM…
April 18, 2022
B.US

Everest Joins Race to Make mRNA Covid Vaccines for China

Company’s move comes as Beijing shows growing signs of approving the new type of high-tech vaccination Key takeaways: Everest will pay up to $150 million or more to potentially bring…
September 21, 2021

Recent Articles

September 30, 2022

AIM Vaccine Shrinks Its IPO But Gives Chairman a Mega Paycheck

April 18, 2022

AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt

B.US
September 21, 2021

Everest Joins Race to Make mRNA Covid Vaccines for China

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

Bamboo Works offers a range of partnerships for corporate and other partners, including opportunities for sponsored content, article-writing services and a wide range of promotions.

About Us
Focus Companies
Fast News
Expert Corner
Premium Content
Facebook Twitter Linkedin Weixin Weibo File-alt

Categories

  • IPO
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Finance
  • Social Media/Entertainment
  • Education
  • New Energy
  • Infrastructure/Resources

Newsletter

For all latest news, offers and special announcements.
Subscribe
Copyright © 2022 Bamboo Works. All rights reserved.